摘要
目的观察联合应用痛泻要方和肠胃康治疗肠易激综合征的效果。方法将2013年9月至2014年9月我院收治的87例肝郁脾虚型肠易激综合征患者作为研究对象,将其随机分为治疗组和对照组。为治疗组45例患者联合应用痛泻要方和肠胃康进行治疗,为对照组42例患者采用匹维溴铵进行治疗,然后对比分析其临床疗效及发生不良反应的情况。结果与对照组患者相比,治疗组患者治疗的总有效率较高,差异显著,有统计学意义(P<0.05)。在进行治疗期间,两组患者均未发生严重的不良反应。与对照组患者相比,治疗组患者在进行治疗后其腹痛、腹泻的主症积分较低,差异显著,有统计学意义(P<0.01)。结论联合应用痛泻要方和肠胃康治疗IBS可取得较理想的效果,显著改善患者的临床症状,而且安全性较高,此法值得在临床上推广应用。
Objective To observe the clinical effect of Tongxieyaofang(TXYF) combined with Changweikang Granule on irritable bowel syndrome(IBS).Methods Eighty seven cases diagnosed with IBS(Liver depression and spleen deficiency syndrome) were randomly divided into two groups.42 patients in control group were treated with Pinaverium Bromide .Meanwhile,45 patients in the treatment group were treated with TXYF and Changweikang Granule for 4 weeks.The improvement of clinical symptoms and adverse effect were observed. Result The total effective rate was 93.3% and 54.8% in treatment group and control group respectively.There were significant statistical difference between the two groups (P<0.005) .Remission of abdominal pain and diarrhea after treatment in treatment group was significantly better than the control group (P<0.01).No severe adverse effect was observed in both groups. Conclusion TXYF combined with Changweikang Granule have favorable safety and clinical effect on IBS (Liver depression and spleen deficiency syndrome).
关键词
肠易激综合征
痛泻要方
肝郁脾虚
肠胃康
irritable bowelsyndrome(IBS)
T ongxieyaofang(TXYF)
Liver depression and spleen deficiency syndrome
Changweikang Granule
